| Dr Lee-loung Liou, MD, PHD | |
|
1959 Ne Pacific St, C212, Box 356340, Seattle, WA 98195-6340 | |
| (206) 543-0065 | |
| Not Available |
| Full Name | Dr Lee-loung Liou |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 21 Years |
| Location | 1959 Ne Pacific St, Seattle, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013022151 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | ML20008373 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Swedish Edmonds Hospital | Edmonds, WA | Hospital |
| Swedish Medical Center / Cherry Hill | Seattle, WA | Hospital |
| Swedish Medical Center | Seattle, WA | Hospital |
| Swedish Issaquah | Issaquah, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Swedish Health Services | 0244138196 | 834 |
| Premere Rehab Llc | 2567434764 | 88 |
News Archive
If findings of a new study in mice are any indication, it might be possible to fine-tune cellular powerhouses called mitochondria, tweaking one aspect to increase insulin sensitivity, reduce body and fat mass, and even extend life. Exploiting this target could one day lead to novel treatments for type 2 diabetes - an endocrine system disease that affects 8 percent of the U.S. population. The research also points to promising new avenues of investigation in the biology of aging.
In a novel use of the CRISPR/Cas9 system, which can be deployed to switch genes off, researchers from Germany, the UK and Spain have developed a multiplexed screening approach to study and model cancer development in mice. The scientists mutated genes in the adult mouse liver uncovering their cancer-causing roles and determining which combinations of genes cooperate to cause liver cancer.
Patients on long-term anticoagulation therapy who test their own blood-clotting time from home and continue to be managed by their GP are significantly less likely to experience a thromboembolic event, according to Oxford University researchers.
McMaster University pediatric cancer specialist Dr. Ronald Barr says the teen gap in cancer care has been overlooked for far too long.
› Verified 1 days ago
| Entity Name | Swedish Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689612954 PECOS PAC ID: 0244138196 Enrollment ID: O20031230000187 |
News Archive
If findings of a new study in mice are any indication, it might be possible to fine-tune cellular powerhouses called mitochondria, tweaking one aspect to increase insulin sensitivity, reduce body and fat mass, and even extend life. Exploiting this target could one day lead to novel treatments for type 2 diabetes - an endocrine system disease that affects 8 percent of the U.S. population. The research also points to promising new avenues of investigation in the biology of aging.
In a novel use of the CRISPR/Cas9 system, which can be deployed to switch genes off, researchers from Germany, the UK and Spain have developed a multiplexed screening approach to study and model cancer development in mice. The scientists mutated genes in the adult mouse liver uncovering their cancer-causing roles and determining which combinations of genes cooperate to cause liver cancer.
Patients on long-term anticoagulation therapy who test their own blood-clotting time from home and continue to be managed by their GP are significantly less likely to experience a thromboembolic event, according to Oxford University researchers.
McMaster University pediatric cancer specialist Dr. Ronald Barr says the teen gap in cancer care has been overlooked for far too long.
› Verified 1 days ago
| Entity Name | Providence Health & Services- Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124270715 PECOS PAC ID: 8325100480 Enrollment ID: O20081224000111 |
News Archive
If findings of a new study in mice are any indication, it might be possible to fine-tune cellular powerhouses called mitochondria, tweaking one aspect to increase insulin sensitivity, reduce body and fat mass, and even extend life. Exploiting this target could one day lead to novel treatments for type 2 diabetes - an endocrine system disease that affects 8 percent of the U.S. population. The research also points to promising new avenues of investigation in the biology of aging.
In a novel use of the CRISPR/Cas9 system, which can be deployed to switch genes off, researchers from Germany, the UK and Spain have developed a multiplexed screening approach to study and model cancer development in mice. The scientists mutated genes in the adult mouse liver uncovering their cancer-causing roles and determining which combinations of genes cooperate to cause liver cancer.
Patients on long-term anticoagulation therapy who test their own blood-clotting time from home and continue to be managed by their GP are significantly less likely to experience a thromboembolic event, according to Oxford University researchers.
McMaster University pediatric cancer specialist Dr. Ronald Barr says the teen gap in cancer care has been overlooked for far too long.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lee-loung Liou, MD, PHD 1959 Ne Pacific St, C212, Box 356340, Seattle, WA 98195-6340 Ph: (206) 543-0065 | Dr Lee-loung Liou, MD, PHD 1959 Ne Pacific St, C212, Box 356340, Seattle, WA 98195-6340 Ph: (206) 543-0065 |
News Archive
If findings of a new study in mice are any indication, it might be possible to fine-tune cellular powerhouses called mitochondria, tweaking one aspect to increase insulin sensitivity, reduce body and fat mass, and even extend life. Exploiting this target could one day lead to novel treatments for type 2 diabetes - an endocrine system disease that affects 8 percent of the U.S. population. The research also points to promising new avenues of investigation in the biology of aging.
In a novel use of the CRISPR/Cas9 system, which can be deployed to switch genes off, researchers from Germany, the UK and Spain have developed a multiplexed screening approach to study and model cancer development in mice. The scientists mutated genes in the adult mouse liver uncovering their cancer-causing roles and determining which combinations of genes cooperate to cause liver cancer.
Patients on long-term anticoagulation therapy who test their own blood-clotting time from home and continue to be managed by their GP are significantly less likely to experience a thromboembolic event, according to Oxford University researchers.
McMaster University pediatric cancer specialist Dr. Ronald Barr says the teen gap in cancer care has been overlooked for far too long.
› Verified 1 days ago
Dr. Herbert Orenstein, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 901 Boren Avenue, #702, Seattle, WA 98104 Phone: 206-623-7444 Fax: 206-623-7445 | |
Dr. Rebecca Mae Allen, MD, MPH Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 805 Madison St Ste 401, Seattle, WA 98104 Phone: 206-467-6300 | |
Monica Kristin Samelson, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1613 E Alder St, Seattle, WA 98122 Phone: 206-558-5495 | |
Roy D Clark Jr., MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 509 Olive Way, #531, Seattle, WA 98101 Phone: 206-682-5203 Fax: 206-682-5304 | |
Julia H Murray, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 4800 Sand Point Way Ne, Seattle, WA 98105 Phone: 206-987-2000 | |
Marcio A Sotero De Menezes, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 600 Broadway Ste 400, Seattle, WA 98122 Phone: 206-215-1440 Fax: 206-215-1441 |